Alzamend Neuro

Alzamend Neuro is a clinical-stage biopharmaceutical company based in Newport Beach, CA. They are dedicated to developing innovative treatments for Alzheimer's disease, Bipolar disorder, Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD). Their mission is to provide safe and effective therapies to the millions of Americans suffering from these debilitating conditions. Alzamend Neuro's pipeline includes two promising drug candidates, AL001 and ALZN002, which aim to deliver targeted treatments for these neurological disorders.

With a focus on research and innovation, Alzamend Neuro is committed to making a significant impact in the field of neurology. Their therapeutic drug candidates, licensed from the University of South Florida Research Foundation, utilize patented technologies to deliver effective treatments. By addressing the unmet medical needs of patients, Alzamend Neuro aims to improve the lives of individuals affected by Alzheimer's disease, Bipolar disorder, MDD, and PTSD.

Generated from the website